A session on Huntington's disease included papers on the properties and connectivity of striatal tissue grafts in rodent models, as well as papers on mechanisms through which striatal grafts produce functional effects, behavioral models, and studies in a primate model.
Transplantation consisted of a total of 330 papers, including 236 submitted papers. Of the submitted papers, 27 were selected for oral presentation and 209 were chosen for poster presentation. In addition, there were 94 invited oral presentations. The total number of papers in the symposium series continues to increase, from 215 papers presented in Rochester in 1987 and the 233 papers presented in Cambridge in 1989, representing a remarkable continued increase in participation and expansion of the field. The overall quality of the material presented was outstanding, and there was a substantial participation of scientists from various fields related to neural transplantation, including studies of neurotrophins and other growth factors, CNS immunology, and brain development.
The following report represents a selective discussion of papers which were presented at the meeting. The amount of material presented was vast, and no attempt has been made to be comprehensive. Thus 
HUNTINGTON'S DISEASE
A session on Huntington's disease included papers on the properties and connectivity of striatal tissue grafts in rodent models, as well as papers on mechanisms through which striatal grafts produce functional effects, behavioral models, and studies in a primate model.
Graybiel and associates/52/described a wellknown excitotoxic model of Huntington's disease and its use for studies of transplantation. Differentiation of striatal tissue was studied following transplantation into the brain, using immunocytochemical markers to characterize the grafts. The striatal phenoytype was found to be expressed, but only in parts or regions of the grafts. Several striatal markers are expressed in patches of striatal-like tissue, in a "matrix" er "surround" of non-striatal tissue.
In normal striatum, c-los expressk,n (an early marker of cell activation) in striatal cells is turned on by cocaine, but only in those cells that Most of the behavioral studies of striatal tissue grafts have employed hyperactivity induced by excitotoxic lesions of the striatum as a behavioral measure. Striatal grafts reverse this hyperactivity over the course of 3 9 weeks after transplantation, and also can reverse amphetamine-induced hyperactivity. More complex skilled behavioral tasks which are impaired following excitotoxic lesions of the striatum, such as paw reaching and grasping of food pellets, are also improved following striatal tissue grafts. Another model which has been employed to assess the effects of striatal tissue transplants is the use of rotational behavior in response to apomorphine. One pitfall in the use of this technique is that the rotational behavior appears to vary with the specific lesion location: More posterior lesions tend to produce ipsilateral rotation, while more anterior lesions produce more contralateral rotation. Sensitization caused by repeated apomorphine injections must also be taken into account when using rotational behavior to assesss the effects of grafts. Also, changes in the form of rotation can occur: Animals may pivot in one spot, or they may walk around in circles using all four paws. The A particularly interesting finding was that GAP-43 expression, a marker for elongating neurites, was highly expressed in grafts for the first 30 days after transplantation, and decreased to baseline levels by 90 to function through at least two separate mechanisms to decrease apomorphine-induced rotation. The first, which is abolished by adrenalectomy, appears to be associated with increases in blood dopamine and is similar for animals that receive grafts of adrenal medulla and sciatic nerve or sham transplantation. The second is a specific effect of adrenal medulla grafts, which is similar in adrenalectomized and normal animals. Since decreases in amphetamine-induced rotation, rather than apomorphine-induced rotation, appear to be related to changes in blood-brain barrier function, it appears likely that adrenal medulla grafts can induce changes in behavior through more than one cellular mechanism.
A theme which was developed throughout the meeting was the possibility of improvements in the efficacy, as well as the survival, of chromaffin cells in transplanted adrenal medulla. Transplantation of adrenal medulla is an area which has been motivated by two ultimate goals; first, the treatment of Parkinson's disease /41,50/, and second, the use of adrenal chromaffin cell implants for the treatment of intractible pain /117,119/.
Studies related to Parkinson's disease will be discussed in more detail below, and studies in chronic pain will be described in the concluding section on new models and applications.
A thorough review of the effects of adrenal medulla autografts, including the multi-center trial and registry data, was presented by Goetz / were somewhat variable. In patient number two, a substantial improvement in relative "on" and "off" times was noted. There was no change in the third patient, who had been followed for only three months. On timed motor tests, patients number one and two were improved somewhat in pronation/ supination, hand/arm movements, and a stand/walk/sit test, but only slightly improved in finger dexterity.
Data from Madrazo and coworkers /90/ on four patients, ages [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] years, who had received adrenal medulla and peripheral (intercostal) nerve co-grafts, were presented by Franco-Bourland. Although some improvements were seen in all patients, in three of the four the improvements in UPDRS scores were considerably less than the mean improvement seen in a series of 18 patients who had received adrenal medulla-only grafts. These improvements were said to be similar to the improvements seen in poorer responders to adrenal medulla-only grafts. Substantial improvement, similar to the mean improvement in patients with adrenal medulla-only grafts, was seen in only one patient. Taken together, the three studies /85,90, 150,151/do not provide, at least up to the present time, strong support for the possibility that the clinical effects produced by the co-grafting method are more substantial than the changes produced after adrenal medulla grafts alone.
The final presentation, from Olson et al. /103/ presented by Hoffer, described a possible alternative method for improving the clinical effects of adrenal medulla grafts by combining the grafts with infusions of NGF. Data from three patients were presented. The first patient, who has already been described in a published paper, showed some prolonged improvements/102/. In a second patient, there were some improvements, including a dampening of "on"-"off" cycling, but these had disappeared after about six months. In a third patient, who had so far been followed for only about six weeks, there were substantial improvements in walking, standardized tests of motor function, and Brightschaft potentials on the operated side. These patients will continue to be monitored.
In addition to the possibility of increasing chromaffin cell survival and effiicacy by co-grafts or NGF administraton, two additional techniques to increase chromaffin cell survival were described. A very interesting study /76,123,124/ Each of 70 animals was assigned a score of "0" to "4", based on ratings and measurements of behavioral impairment following MPTP administration. The score of "0" was used for normal, untreated subjects, and "1" represented subtle deficits in object retrieval but not gross motor deficit. Scores of "2" through "4" represented increasingly severe parkinsonian motor impairment. The more severe the initial deficits, the less rapidly the animals showed spontaneous recovery. Monkeys with ratings of "1" showed spontaneous recovery within one month, while animals with scores of "4" did not recover during 5 months of assessment. Improvements after SN transplantation were observed in category "1", "2", "3", and "4" subjects. Improvements were not seen after control surgical procedures. Category "4" subjects tended to have medical complications and were difficult to maintain; SN grafts were found to increase the percentage of category "4" subjects which survived for more than three months. Donors ranged from 4-5 weeks (7 9 mm crownrump length) to 10.5 weeks of fetal age. Data were evaluated in terms of survival of THimmunoreactive cells and host reafferentation. It was found that dissociated cell grafts survived best when the donors were between 5 and 8 weeks of age (E34 to E56). Poor cell survival was obtained when the donors were older than 9 weeks (E65).
For solid tissue grafts, however, E37 donor tissue resulted in only modest cell survival. The best cell survival was obtained with donors between 6 and 9 weeks (E43 to E65). No survival was obtained for grafts older than E72, or slightly greater than 10 weeks. These data provide the first direct comparison of solid and dissociated cell grafts in terms of age requirements for cell survival, and confirm previous data suggesting that tissue no older than 9 weeks for dissociated grafts and 10 weeks for solid grafts must be use,,. r anything, these data suggest that the age limit for solid tissue grafts is somewhat earlier than previously thought. It seems probable, therefore, that tissue of fetal age 11 weeks or greater is not likely to reafferent host striatum when used for clinical studies.
One issue which is a concern regarding the use of fetal SN grafts in human patients, is whether the grafts may be damaged by drugs especially L-DOPA-which are routinely administered to patients with Parkinson's disease. Steece-Collier and coworkers /135,136/ reported that L-DOPA impairs the survival and neurite outgrowth from primary dopaminergic neurons in tissue culture. Effects of chronic L-DOPA treatment on SN grafts, made by injection of solid fragments of SN directly into the striatum, were also examined.
Morphological development of the THimmunoreactive neurons seemed to be impaired, in terms of neurite development and size of the neurons, although the number of surviving neurons was not decreased. Steece-Collier /136/ presented additional data on the effects of L-DOPA treatment on SN grafts. It was found that the effects of SN grafts on amphetamine-induced rotation, measured six weeks after transplantation, were greatly diminished in animals that had received chronic administration of 50 mg/kg of L-DOPA i.p., twice per day, as compared to saline-treated controls. The administration of L-DOPA was discontinued after six weeks. In the saline-treated controls, the decreases in rotational behavior were maintained when retested at 12 weeks. In the L-DOPA-treated animals, six weeks after withdrawal there was a non-significant reduction in rotation, although not to the level of the controls. When data from individual animals was examined, it appeared that there was a tendency for recovery in half of the animals, but the other half of the animals did not recover. Van which may serve as a model is the cadaveric donation framework. These guidelines treat the fetus as a cadaver but do not, however, address the possible concerns or role of the mother as a donor. Additional provisions may be needed related to the special circumstances of fetal transplantation, to provide for protection of both the fetus and the mother. Details of the guidelines that have been proposed or set up for various countries were described and compared. These Three patients reported by Dymecki and coworkers /34/ received fetal tissue grafts from 11-12 week getstational donors into the head of the caudate nucleus using a method similar to the Madrazo /91/ technique but with a specially designed instrument. These patients had been followed for 30, 20 , and 12 months. Improvement according to a number of parameters was observed starting 3 to 6 months after surgery and was sustained for the entire observation period. This study included assessments of motor performance using timed tasks; for example, there were improvements in foot lifting, pronation/supination, and finger dexterity of the order of 30 to 50%.
Percentage of the day spent in "off" phase decreased from 55% before transplantation to 17-18% from 9 to 30 months after transplantation.
Lindvall /84/ discussed the results of fetal SN transplantation, using dissociated cell grafts, in four patients with idiopathic Parkinson's disease. The two patients with MPTP-induced parkinsonism described by Widner implications for other clinical studies was that ratings using the UPDRS showed improvements in the operated patients and also in the controls; nonetheless, the improvements in the operated group were somewhat smaller. Also, the controls self-rated themselves as being considerably improved, but the objective raters did not observe as much improvement in the control group.
There was one death, which appeared to be unrelated to the experimental procedure. depolarization, suggesting a role of aeetyleholine release in the behavioral recovery. Afferents from the cortical grafts were found to extend into the host thalamus and amygdala, with these connections developing over a 60-day time course, roughly parallelling the time course of behavioral recovery. Based on the hypothesized role of acetylcholine in the behavioral recovery, effects of NGF were examined. NGF was found to accelerate the time-course of behavioral recovery after insular cortex grafts, but had no effect on the long-term outcome. NGF had no effect alone or when combined with occipital cortex grafts. One interesting aspect of these experiments/9/is that they suggest a specific neuroehemical mediation (i.e., acetylcholine) of a behavioral response to cortical tissue transplantation. A novel transplantation model described by Sortwell 
